Priority Date: 18.06.10 (US 20100356265P)

METHOD FOR PREDICTING A THERAPY RESPONSE IN SUBJECTS WITH MULTIPLE SCLEROSIS

  • Application ID: EP11796478
  • Status: APPLICATION WITHDRAWN

Applicant

Research organisation logo small
Research Organisation

Attorney

operating since 1912
Headquarter in London and 3 offices
active in Legal Services and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco, Lederer Keller Patentanwälte Partnerschaft mbB and 184 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 18.06.2010 - Priority Date (US 20100356265P)
  • 22.12.2011 - Publication A2 (WO2011159970)
  • 01.05.2013 - Publication A2 (EP2585100)